Kytel Therapeutics is an India-based pharmaceutical company specialising in the development, registration and supply of high-quality finished formulations from WHO-GMP certified manufacturers to pharma companies, importers and distributors across Africa.
Kytel operates on a demand-led, partnership-driven model. We work closely with local distributors to identify portfolio gaps and market requirements, then evaluate, develop and register suitable products under the Kytel brand for long-term commercialisation in their markets.
Supplying a growing network of African markets.
Kytel sources from a vetted network of WHO-GMP and ISO certified Indian manufacturing partners that hold the relevant export-country FDA facility registrations.
Export enabled to 6+ markets across East and West Africa, with a growing brand presence.
Focused formulations, built around market demand.